| |
| |
|
| Insider
Information: |
Becker Daniel J. |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
8,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,040 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
8,000 |
|
|
| Total
Value |
$14,040 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -71.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Principia Biopharma Inc |
PRNB |
Director |
2018-09-18 |
0 |
2020-09-28 |
0 |
Premium* |
|
|
Pandion Therapeutics, Inc. |
PAND |
Director |
2021-04-01 |
0 |
2021-04-01 |
0 |
Premium* |
|
|
Day One Biopharmaceuticals, Inc. |
DAWN |
Director |
2021-06-01 |
5,000 |
2021-06-01 |
0 |
Premium* |
|
|
Acelyrin, Inc. |
SLRN |
Director |
2023-05-09 |
3,000 |
2023-05-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLRN |
Acelyrin, Inc. |
Director |
– • – |
2023-05-09 |
4 |
B |
$18.00 |
$54,000 |
D/D |
3,000 |
3,000 |
2.39 |
% |
|
| DAWN |
Day One Biopharmaceutical... |
Director |
– • – |
2021-06-01 |
4 |
B |
$16.00 |
$80,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • – |
2021-04-01 |
4 |
D |
$60.00 |
$169,672,980 |
I/I |
(2,827,883) |
0 |
0 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • – |
2021-04-01 |
4 |
D |
$60.00 |
$60,000 |
D/D |
(1,000) |
0 |
0 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • – |
2020-11-19 |
4 |
B |
$15.12 |
$2,989,466 |
I/I |
197,716 |
2,827,883 |
2.1 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • – |
2020-11-18 |
4 |
B |
$15.26 |
$216,646 |
I/I |
14,197 |
2,630,167 |
2.1 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • – |
2020-11-17 |
4 |
B |
$14.63 |
$232,754 |
I/I |
15,197 |
2,615,970 |
2.1 |
- |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • – |
2020-09-28 |
4 |
D |
$100.00 |
$66,760,000 |
I/I |
(667,600) |
0 |
0 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2020-07-21 |
4 |
B |
$18.00 |
$18,000 |
D/D |
1,000 |
1,000 |
3.92 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2020-07-21 |
4 |
B |
$18.00 |
$12,999,996 |
I/I |
722,222 |
2,600,773 |
2.25 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
1,878,551 |
1,878,551 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • – |
2019-11-20 |
4 |
B |
$29.94 |
$1,646,700 |
I/I |
55,000 |
667,600 |
2.1 |
- |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • – |
2019-10-29 |
4 |
B |
$33.98 |
$312,477 |
I/I |
9,196 |
612,600 |
2.1 |
- |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • – |
2019-10-28 |
4 |
B |
$33.41 |
$2,285,549 |
I/I |
68,404 |
603,404 |
2.1 |
- |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • – |
2019-10-18 |
4 |
B |
$28.00 |
$14,980,000 |
I/I |
535,000 |
535,000 |
2.1 |
- |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • • |
2018-09-18 |
4 |
B |
$17.00 |
$4,590,000 |
I/I |
270,000 |
437,537 |
2.25 |
- |
|
| PRNB |
Principia Biopharma Inc |
Director |
– • • |
2018-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,355,713 |
167,537 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
